2d And 3d Binding Mode Of Compound 10 In The Binding Site Of The Egfr

2D and 3D binding mode of compound 10 in the binding site of the EGFR ...
2D and 3D binding mode of compound 10 in the binding site of the EGFR ...
2D and 3D binding mode of compound 10 in the binding site of the EGFR ...
2D and 3D binding mode of compound 10 in the binding site of the EGFR ...
2D and 3D binding mode of compound 10 in the binding site of the EGFR ...
2D and 3D binding mode of compound 10 in the binding site of the EGFR ...
2D and 3D binding mode of compound 13 in the binding site of the EGFR ...
2D and 3D binding mode of compound 13 in the binding site of the EGFR ...
2D and 3D binding mode of compound 18 in the binding site of the EGFR ...
2D and 3D binding mode of compound 18 in the binding site of the EGFR ...
2D and 3D binding mode of compound 16 in the binding site of the EGFR ...
2D and 3D binding mode of compound 16 in the binding site of the EGFR ...
(a) 2D and 3D binding mode of compound 10 inside the active site of ...
(a) 2D and 3D binding mode of compound 10 inside the active site of ...
3D and 2D binding mode of Gefitinib in the active site of EGFR receptor ...
3D and 2D binding mode of Gefitinib in the active site of EGFR receptor ...
(a) 2D and 3D binding mode of compound 10 inside the active site of ...
(a) 2D and 3D binding mode of compound 10 inside the active site of ...
3D and 2D binding mode of erlotinib into the active site of EGFR WT ...
3D and 2D binding mode of erlotinib into the active site of EGFR WT ...
3D and 2D binding mode of erlotinib into the active site of EGFR WT ...
3D and 2D binding mode of erlotinib into the active site of EGFR WT ...
3D and 2D binding interactions of compound 20 in the active site of the ...
3D and 2D binding interactions of compound 20 in the active site of the ...
(a) The 3D and (b) 2D predicted binding mode of the compound 3k in the ...
(a) The 3D and (b) 2D predicted binding mode of the compound 3k in the ...
3D and 2D binding pattern of designed compound 6 in the active site of ...
3D and 2D binding pattern of designed compound 6 in the active site of ...
((a) and (b)) 2D and 3D representation of the binding mode of compound ...
((a) and (b)) 2D and 3D representation of the binding mode of compound ...
((a) and (b)) 2D and 3D representation of the binding mode of compound ...
((a) and (b)) 2D and 3D representation of the binding mode of compound ...
The binding mode of the compound 6i in the active site of EGFR: a 3D ...
The binding mode of the compound 6i in the active site of EGFR: a 3D ...
((a) and (b)) 2D and 3D representation of the binding mode of compound ...
((a) and (b)) 2D and 3D representation of the binding mode of compound ...
((a) and (b)) 2D and 3D representation of the binding mode of compound ...
((a) and (b)) 2D and 3D representation of the binding mode of compound ...
((a) and (b)) 2D and 3D representation of the binding mode of compound ...
((a) and (b)) 2D and 3D representation of the binding mode of compound ...
2D and 3D binding nature of compound 6 in the binding pocket of the ...
2D and 3D binding nature of compound 6 in the binding pocket of the ...
Shows Figure 2D and 3D of the binding of compound 10 with the target ...
Shows Figure 2D and 3D of the binding of compound 10 with the target ...
2D and 3D binding of the most potent compound 32 in the binding pockets ...
2D and 3D binding of the most potent compound 32 in the binding pockets ...
2D and 3D binding nature of compound 6 in the binding pocket of the ...
2D and 3D binding nature of compound 6 in the binding pocket of the ...
Binding mode of Compound 10 in the active site of 2PFR along with ...
Binding mode of Compound 10 in the active site of 2PFR along with ...
A 3D binding mode of 103, B 2D binding mode of 103 in the active site ...
A 3D binding mode of 103, B 2D binding mode of 103 in the active site ...
2D and 3D view of the target compounds (6-10) docked in ATP binding ...
2D and 3D view of the target compounds (6-10) docked in ATP binding ...
The proposed binding mode of compound 5a docked in the active site of ...
The proposed binding mode of compound 5a docked in the active site of ...
The proposed binding mode of compound 3 docked in the active site of ...
The proposed binding mode of compound 3 docked in the active site of ...
Description of the compounds that bind to the binding site A in 2D and ...
Description of the compounds that bind to the binding site A in 2D and ...
3D binding mode and residues involved in the recognition of active ...
3D binding mode and residues involved in the recognition of active ...
The binding mode of EGFR with 20c. (A) The 3D structure of complex. (B ...
The binding mode of EGFR with 20c. (A) The 3D structure of complex. (B ...
The 2D and 3D binding interactions of compounds (10, 12, 20, 21, 23 ...
The 2D and 3D binding interactions of compounds (10, 12, 20, 21, 23 ...
(A) 3D binding mode of compound 10 against IL-6 protein, (B) 2D binding ...
(A) 3D binding mode of compound 10 against IL-6 protein, (B) 2D binding ...
(A) 3D binding mode of compound 10 against TNF-a protein, (B) 2D ...
(A) 3D binding mode of compound 10 against TNF-a protein, (B) 2D ...
Represented the 2D and 3D binding modes of (A) co-crystallized ligand ...
Represented the 2D and 3D binding modes of (A) co-crystallized ligand ...

Loading image details...

Source
Dimensions